Quest PharmaTech Inc. (QPTFF)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.31 Million CAD | 52.17% |
| 2022 | -3.46 Million CAD | 94.05% |
| 2021 | -788.7 Thousand CAD | -135.67% |
| 2020 | -1.06 Million CAD | 1298.62% |
| 2019 | -13.62 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -795.74 Thousand CAD | -105.49% |
| 2024 Q2 | 329.4 Thousand CAD | 191.19% |
| 2023 Q2 | -10.1 Million CAD | -9975.87% |
| 2023 Q4 | 15.58 Million CAD | 916.93% |
| 2023 FY | - CAD | 52.17% |
| 2023 Q1 | -100.31 Thousand CAD | -234.39% |
| 2023 Q3 | -1.9 Million CAD | 81.12% |
| 2022 Q3 | -149.8 Thousand CAD | 0.0% |
| 2022 FY | - CAD | 94.05% |
| 2022 Q4 | -30 Thousand CAD | 79.97% |
| 2021 FY | - CAD | -135.67% |
| 2020 FY | - CAD | 1298.62% |
| 2019 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 98.152% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 77.857% |
| SQZ Biotechnologies Company | -64.14 Million USD | 97.953% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 92.442% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 101.396% |
| Mesoblast Limited | -62.38 Million USD | 97.896% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 14.531% |
| Genus plc | 73.7 Million USD | 101.781% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 80.143% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 62.987% |
| Marizyme, Inc. | -34.28 Million USD | 96.17% |
| ContraFect Corporation | -64.99 Million USD | 97.98% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 85.034% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 70.994% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 6.346% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 50.355% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 43.505% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -153.423% |
| Accustem Sciences Inc. | -3.74 Million USD | 64.957% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 97.278% |
| EV Biologics, Inc. | -1.26 Million USD | -3.608% |
| Q BioMed Inc. | -617.62 Thousand USD | -112.563% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 136.754% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -107.596% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 42.532% |
| Biomind Labs Inc. | -1.03 Million USD | -26.901% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 113.292% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 81.667% |
| Skye Bioscience, Inc. | -13.54 Million USD | 90.309% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 11.736% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -5151.392% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 66.201% |
| IMV Inc. | -35.52 Million USD | 96.304% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 91.727% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 47.527% |
| GB Sciences, Inc. | -1.41 Million USD | 7.538% |
| Alpha Cognition Inc. | -9.7 Million USD | 86.473% |
| HST Global, Inc. | -5303.00 USD | -24656.704% |
| CSL Limited | 4.78 Billion USD | 100.027% |
| Halberd Corporation | -74.27 Thousand USD | -1667.455% |
| Enzolytics Inc. | -2.12 Million USD | 38.132% |
| Resverlogix Corp. | -11.74 Million USD | 88.819% |
| Affymax, Inc. | -14.29 Million USD | 90.816% |
| SYBLEU INC | -141.57 Thousand USD | -827.342% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 57.139% |
| argenx SE | -216.02 Million USD | 99.392% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 97.628% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 207.876% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 12.413% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 446.541% |
| AVAX Technologies, Inc. | -6.11 Million USD | 78.522% |
| Zenith Capital Corp. | -8.6 Million USD | 84.745% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.472% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -7436.008% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 46.337% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -645.833% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 96.688% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 54.609% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -25.474% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 19624.807% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 24.98% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 31.655% |
| BioStem Technologies, Inc. | -7.55 Million USD | 82.62% |
| ONE Bio Corp. | 13.61 Million USD | 109.644% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -624.978% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 36.177% |
| Agentix Corp. | -1.37 Million USD | 4.294% |
| LadRx Corporation | 412.28 Thousand USD | 418.434% |
| Cell Source, Inc. | -4.27 Million USD | 69.272% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -257.509% |
| Regen BioPharma, Inc. | 1.46 Million USD | 189.556% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -40.119% |
| NovAccess Global Inc. | -1.03 Million USD | -26.87% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 114.828% |
| Itoco Inc. | -1.86 Million USD | 29.756% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -245.832% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -17.639% |
| Kadimastem Ltd | -2.62 Million USD | 49.975% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -448.964% |
| CytoDyn Inc. | -18.02 Million USD | 92.718% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -1561.223% |
| Mobile Lads Corp. | -2.24 Million USD | 41.421% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -10635.53% |
| Qrons Inc. | -40.08 Thousand USD | -3175.487% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -170.312% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 348.913% |
| Rebus Holdings, Inc. | -951 Thousand USD | -38.049% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -23.619% |
| International Stem Cell Corporation | 202 Thousand USD | 749.925% |
| Bioxytran, Inc. | -3.82 Million USD | 65.634% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -2394.012% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 46.674% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 96.34% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -2817.44% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 52.051% |
| Neutra Corp. | -181.24 Thousand USD | -624.342% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 93.488% |
| PureTech Health plc | -11.62 Million USD | 88.709% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 93.487% |
| IXICO plc | -707 Thousand USD | -85.693% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 82.917% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 97.284% |
| CSL Limited | 4.73 Billion USD | 100.028% |
| Cellectis S.A. | -92.63 Million USD | 98.583% |